ABOUT 24th_BEF
> ATTENDEES​​
> INVESTORS​​
> PRESENTERS​​
> EXHIBITORS​​
> SPONSORS​​
> SUPPORTERS​​

+ND Capital
3B Future Health Ventures
3xP Global
4BIO Capital
AATec Medical GmbH
AbbVie, Inc.
abcDNA GmbH
ABYOLO AG
Accequa AB
AdBio Partners
Addex Therapeutics Ltd.
Adoram Therapeutics SA
Advanced BioDesign
Advestra AG
aescuvest GmbH
AFK & Partners LLC
Ageronix SA
Agile Capital Markets
AIPTO TechBio GmbH
AKIGAI AS
Akribion Therapeutics GmbH
Alder Therapeutics AB
AlgenScribe SAS
Aliath Bioventures
Allele Capital Partners
ALSA Ventures
Amarna Therapeutics
AMR Action Fund GP GmbH
Anaveon AG
Andera Partners SA
Angelini Ventures S.p.A.
ANNIMO Health EDC AG
Antisoma Venture Capital Fund S.A
Apogenix i.L.
Apollo Health Ventures
ArchiMed
Ardena
Ariceum Therapeutics GmbH
Ariya Bio c/o ETH Zürich
ARVE Capital GmbH
Asahi Kasei Europe GmbH
Asahi Kasei Pharma Corporation
Asahi Kasei Ventures
Asklepios Advisors
Astellas Pharma Europe Ltd.
AstraZeneca
Atamyo Therapeutics SAS
Atopia Therapeutics
Aukera Therapeutics GmbH
Aurealis Therapeutics AG
AurorA Science Srl
AVANTECA Partners AG
Avata Biosciences
Avego Bioscience Capital
Awen GmbH
AXA Investment Managers
BaseLaunch
BD as a Service
Bellevue Asset Management AG
Bergaud & Partners
Bergmann zur Hausen & Cie. GmbH
BERNINA BioInvest Ltd.
Bio Med Gene Ventures
BioGeneration Ventures
BioMedPartners AG
BiomedVC AG
biomindz Standortentwicklungsgesellschaft Mainz mbH
Bioqube Ventures
BIOSTART Consulting GmbH
Biotx.ai, GmbH
BioValley Basel
Biovance Capital
Biovision Ventures
BiPER Therapeutics
Bird & Bird LLP
BlackRock Advisors, LLC
Bloom Science, Inc.
Bloomberg Intelligence
BlueSky Immunotherapies GmbH
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Venture Fund GmbH
BOLD Longevity Growth Fund
Bootstrap Europe
Bradley Woods & Co. Ltd.
Brenus Pharma
Breslin AG
British Patient Capital
BROTHERS & Partners Europe
Business Angels Switzerland
Calida Therapeutics SAS
Calliditas Therapeutics AB
Camallergy
Canton of Basel-Stadt
Cantoni Therapeutics BV
Capital Grand Est
Carma Fund
Carmouflage
CaSRevolution S.r.l.
Catalpa Ventures S.à r.l.
CDP Venture Capital SGR ​S.p.A.
CDP Venture Capital SGR S.p.A.
Cellestia Biotech AG
cellvie Inc.
Changchun GeneScience Pharmaceutical Co., Ltd
Charles Consultants (Life Sciences) Limited
Chugai Venture Fund, LLC
CIS BIOPHARMA AG
Claris Ventures
Clave Capital
CMS Medical Venture Investment Ltd.
CNS Pharmaceuticals, Inc.
Cohesion Bureau
Convergence Partners AG
Corden Pharma International Switzerland LLC
Coulter Partners
Cukierman & Co. Life Sciences
Cullgen Inc.
Cumulus Oncology
Curaxon AG
Cureteq AG
Curie.Bio
Danube BioVentures
DeBere Capital Partners
Debiopharm International SA
Delin Ventures Ltd.
Digital Networks PLC
Dimericon Therapeutics AG
Droia Ventures NV
éclateral Ltd.
Eczacibasi Pharmaceutical and Industrial Investment Co.
Edison Group
EIT Health e.V.
eleva GmbH
Eli Lilly and Company
Elpiscience Biopharmaceuticals Co. Ltd.
Endeavor Life Science Venture Fund
ENV Ventures
EQT Life Sciences
European Investment Bank
European Investment Fund
Evariste
Evernow Publishing Ltd, publisher of MedNous
EvlaBio AG
EVORA Biosciences
Exazyme GmbH
ExperTrials
F. Hoffmann-La Roche AG
Facultas Partners
FastVentures B.V.
FimmCyte AG
Finanz und Wirtschaft / Tamedia
Flagship Pioneering
FluoSphera SA
Forbion
Forty51 Ventures
FoRx Therapeutics AG
Fraser Partners
Fraunhofer IZI (Institute for Cell Therapy and Immunology)
FreeMind Group
Fund+
Fusix Biotech GmbH
G4 FRIENDS LTD.
GALSER SA
Gan & Lee Pharmaceuticals
Generation Fund Life Sciences Fund I
Genius Search GmbH & Co. KG
GenSearch Switzerland GmbH
German Accelerator Life Sciences
GIBF
Gilde Healthcare Partners B.V.
Gimv
GL Capital
GOLDTRACK Ventures GmbH
Grabulovski Consulting Services GmbH
GrowthCube Partners LLC
GSK
Gubra A/S
H Tree Capital
H. Lundbeck A/S
H.C. Wainwright & Co.
Hadean Ventures
Harmonic Discovery Inc.
HBM Partners AG
Heal Capital
Health Innovation Capital
HealthCap
Hephaistos Pharma
Heran Partners BV
Herantis Pharma Plc

High-Tech Gründerfonds
Hitachi Ventures GmbH
IAG Italian Angels for Growth
IAMA Therapeutics S.r.l.
ICF Consult Switzerland
ILC Therapeutics Ltd
Immunyx Pharma
Indaco Venture Partners SGR S.p.A.
Index Capital
InnoGrant Advisors KLG
Innovestor Life Science Ltd.
INOGROUP GmbH
Insilico Medicine
Intercontinental Capital
International Institute for Management Development
Inveready Asset Management
InvestHK
iOnctura SA
IPF Partners
IQVIA
Jeito Capital
JFG Life Sciences Foundation
Johnson & Johnson Innovation LLC
JPMorgan Chase & Co.
Karista
Kerna Ventures
King Bioventures
Kurma Partners
L.E.K. Consulting
Ladenburg Thalmann & Co. Inc.
Landmark Angels, Family Office
Landmark BioVentures AG
Laverock Therapeutics Ltd.
Leads To Development
LifeCare Partners GmbH
LIfT BioSciences Ltd.
Lipocyte BioMed GmbH
LMU Munich
LSA Ventures
LSV Capital Partners
LuSeed Vascular
Lynx Financial Hong Kong Ltd.
Lyonbiopôle
M Ventures
M2Care
Mabylon AG
MEDiSTRAVA Consulting
Memo Therapeutics AG
Merck KGaA, Darmstadt, Germany
Mergermarket
MetrioPharm AG
MexBrain
Mid Atlantic Bio Angels
MIG Capital
Modiblast Pharma GmbH
MSQ Ventures
MUVON Therapeutics AG
MVM Partners LLP
NanoCell Therapeutics, Inc.
Nasdaq
NatIgGs GmbH
Neurevo GmbH, MicroCures.Inc, 3Brain SA
New Science Fund
Nextech Invest Ltd.
NG Bio
NH TherAguix SAS
Nouscom AG
NovAliX SAS
NovaPump GmbH
Novartis AG
Novartis Venture Fund
Novo Holdings A/S
Novo Nordisk A/S
NRW.Venture
Nxera Pharma
NXI Therapeutics AG
NxR Biotechnologies GmbH
Octopus Ventures
Olgram SAS
Omega Funds
Oncode Oncology Bridge Fund
Oncosema
Oncoteq AG
One Up Consulting
Onena Medicines AG
Onward Therapeutics SA
OrbiMed Advisors LLC
Orixha
Oryzon Genomics, S.A.
Ousia Pharma ApS
Palleos Healthcare GmbH
Partex N.V.
Paul Larue Business Development Consulting
PDC*line Pharma SA
Peregrine Ventures
Perseo Pharma AG
Persica Pharmaceuticals Ltd.
Pfizer, Inc.
Pharmaron UK Ltd
Philos & Partners Ltd
Pictet & Cie
Pilatus Biosciences SA
Playground Global
Pleco Therapeutics BV
PMV NV
Preclina Inc.
Prevatex Pty Ltd
PROSION GmbH
PulseSight Therapeutics
Pureos Bioventures
Qiming Venture Partners
Quadrille Capital
Quant Biomarkers AG
Reconnect Labs AG
Redalpine Venture Partners AG
RNATICS GmbH
Roca Therapeutics
Roche Diagnostics
Ropes & Gray LLP
Rosetta Capital Ltd.
Rosetta Omics
RV Invest GmbH
Salvina Therapeutics Inc.
Sand Hill Angels
Scendea Ltd.
SciRhom GmbH
Scius Communications
Scobag Private Bank AG
Secarna Pharmaceuticals GmbH & Co. KG
Second Thought
Seekyo Therapeutics
Selvita S.A.
Seroba Life Sciences
Seventure Partners
Sixty Degree Capital
Skymab Biotherapeutics
Sofinnova Partners
Sound Bioventures Management AB
Staatz BD & Strategy
STALICLA SA
steerBIO GmbH
Stifel
Stimunity SAS
Sulfateq BV
Sunstone Life Science Ventures
SurgiMab S.A.S.
Suterscience GmbH
Swiift Imaging SAS
Swiss Biotech Association
Symeres B.V.
Taiho Ventures, LLC
TargImmune Therapeutics AG
Telomere Therapeutics
Thabor Therapeutics
THERAtRAME S.A.
Thermosome GmbH
Tigermed
TME Pharma
TOLREMO Therapeutics AG
TransCure bioServices SAS
TruVenturo GmbH
TVM Capital Life Science
UBS AG
UCEA Family Office
Umlaut.bio GmbH
Università Svizzera Italiana
University Hospital of Zürich
University of Lausanne
University of Zurich
Urania Therapeutics
V-Bio Ventures BV
Valor Management
Venture Valuation AG
Versant Ventures
Vesalius Biocapital IV Partners SàrL
VI Partners AG
VIB
Viopas Venture Consulting
Vogel BioC
VUS Diagnostics
WBB Securities, LLC
Wellington Partners
Womble Bond Dickinson
WuXi STA
XGEN Venture SGR S.p.A.
XOventure GmbH
YAYA Capital
Ysios Capital
Zinc VC